Slingshot members are tracking this event:
Bristol-Myers Squibb Completes Previously Announced Sale of its HIV R&D Portfolio to ViiV Healthcare
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Feb 22, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Hiv, Viiv Healthcare